Web Release Date: December 8,
Urine Testing for Designer Steroids by Liquid Chromatography with Androgen Bioassay Detection and Electrospray Quadrupole Time-of-Flight Mass Spectrometry Identification
RIKILT Institute of Food Safety, P.O. Box 230, 6700 AE Wageningen, The Netherlands
Received for review July 25, 2005. Accepted November 3, 2005.
Abstract:
New anabolic steroids show up occasionally in sports
doping and in veterinary control. The discovery of these
designer steroids is facilitated by findings of illicit preparations, thus allowing bioactivity testing, structure elucidation using NMR and mass spectrometry, and final
incorporation in urine testing. However, as long as these
preparations remain undiscovered, new designer steroids
are not screened for in routine sports doping or veterinary
control urine tests since the established GC/MS and LC/MS/MS methods are set up for the monitoring of a few
selected ions or MS/MS transitions of known substances
only. In this study, the feasibility of androgen bioactivity
testing and mass spectrometric identification is being
investigated for trace analysis of designer steroids in
urine. Following enzymatic deconjugation and a generic
solid-phase extraction, the samples are analyzed by gradient LC with effluent splitting toward two identical 96-well
fraction collectors. One well plate is used for androgen
bioactivity detection using a novel robust yeast reporter
gene bioassay yielding a biogram featuring a 20-s time
resolution. The bioactive wells direct the identification
efforts to the corresponding well numbers in the duplicate
plate. These are subjected to high-resolution LC using a
short column packed with 1.7-
m C18 material and
coupled with electrospray quadrupole time-of-flight mass
spectrometry (LC/QTOFMS) with accurate mass measurement. Element compositions are calculated and used
to interrogate electronic substance databases. The feasibility of this approach for doping control is demonstrated
via the screening of human urine samples spiked with the
designer anabolic steroid tetrahydrogestrinone. Application of the proposed methodology, complementary to the
established targeted urine screening for known anabolics,
will increase the chance of finding unknown emerging
designer steroids, rather then being solely dependent on
findings of the illicit preparations themselves.
Download the full text: PDF | HTML